Buffington Mohr Mc Neal Merck & Co., Inc. Transaction History

Buffington Mohr Mc Neal

$600 Million
Q4 2024

A detailed history of Buffington Mohr Mc Neal transactions in Merck & Co., Inc. stock. As of the latest transaction made, Buffington Mohr Mc Neal holds 78,571 shares of MRK stock, worth $6.73 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

78,571

Previous 83,726 6.16%

Holding current value

$6.73 Million

Previous $9.51 Million 17.79%

% of portfolio

1.3%

Previous 1.57%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$96.31 - $114.76 $496,478 - $591,587	-5,155 Reduced 6.16%	78,571 $7.82 Million
Q3 2024 Oct 16, 2024	BUY	$111.15 - $128.97 $65,356 - $75,834	588 Added 0.71%	83,726 $9.51 Million
Q2 2024 Jul 11, 2024	BUY	$123.8 - $132.96 $43,453 - $46,668	351 Added 0.42%	83,138 $10.3 Million
Q1 2024 Apr 18, 2024	BUY	$113.24 - $131.95 $684,082 - $797,109	6,041 Added 7.87%	82,787 $10.9 Million
Q4 2023 Jan 30, 2024	BUY	$100.18 - $109.02 $32,859 - $35,758	328 Added 0.43%	76,746 $8.37 Million
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $144,644 - $160,633	-1,405 Reduced 1.81%	76,418 $7.87 Million
Q2 2023 Jul 25, 2023	SELL	$108.61 - $118.38 $368,513 - $401,663	-3,393 Reduced 4.18%	77,823 $8.98 Million
Q1 2023 Apr 26, 2023	BUY	$102.94 - $114.86 $112,101 - $125,082	1,089 Added 1.36%	81,216 $8.64 Million
Q4 2022 Jan 19, 2023	SELL	$87.44 - $112.11 $168,322 - $215,811	-1,925 Reduced 2.35%	80,127 $0
Q3 2022 Oct 11, 2022	BUY	$84.53 - $94.96 $145,391 - $163,331	1,720 Added 2.14%	82,052 $7.07 Million
Q2 2022 Jul 19, 2022	BUY	$83.49 - $94.64 $24,546 - $27,824	294 Added 0.37%	80,332 $7.32 Million
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $182,672 - $204,764	2,485 Added 3.2%	80,038 $6.57 Million
Q4 2021 Jan 27, 2022	BUY	$72.28 - $90.54 $89,771 - $112,450	1,242 Added 1.63%	77,553 $5.94 Million
Q3 2021 Oct 13, 2021	BUY	$71.68 - $78.83 $184,719 - $203,144	2,577 Added 3.49%	76,311 $5.73 Million
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $284,896 - $315,124	4,052 Added 5.81%	73,734 $5.73 Million
Q1 2021 Apr 14, 2021	BUY	$68.86 - $81.11 $3.85 Million - $4.54 Million	55,957 Added 407.7%	69,682 $5.37 Million
Q4 2020 Jan 20, 2021	BUY	$71.77 - $79.65 $151,721 - $168,380	2,114 Added 18.21%	13,725 $1.12 Million
Q3 2020 Oct 26, 2020	BUY	$73.18 - $82.95 $95,060 - $107,752	1,299 Added 12.6%	11,611 $963,000
Q2 2020 Jul 27, 2020	BUY	$70.42 - $80.13 $100,841 - $114,746	1,432 Added 16.13%	10,312 $797,000
Q1 2020 Apr 08, 2020	BUY	$63.36 - $87.82 $137,491 - $190,569	2,170 Added 32.34%	8,880 $683,000
Q3 2019 Oct 10, 2019	SELL	$76.08 - $82.93 $26,628 - $29,025	-350 Reduced 4.96%	6,710 $565,000
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $18,577 - $21,702	-266 Reduced 3.63%	7,060 $592,000
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $2,087 - $2,380	-30 Reduced 0.41%	7,326 $609,000
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $15,200 - $17,640	233 Added 3.27%	7,356 $562,000
Q2 2018 Jul 30, 2018	BUY	$50.83 - $59.72 $362,062 - $425,385	7,123 New	7,123 $432,000

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $217B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buffington Mohr Mc Neal, based on Form 13F filings with the SEC.

News

Stay updated on Buffington Mohr Mc Neal with notifications on news.

Account

Buffington Mohr Mc Neal Merck & Co., Inc. Transaction History